Essilor prescription safety eyeglasses are your ultimate solution for employee vision protection. As the leading manufacturer of prescription lenses in the U.S., Essilor is proud to offer our superior lens technology and innovation in prescription safety glasses. Our dedication to exceptional quality and devotion to rigorous research and development is evident in every aspect of our Safety Lens category. Essilor is passionate about performance, and it shows. Our prescription safety glasses feature exclusive lens technology from our family of premium brands, like Varilux®, Crizal® and Transitions® adaptive lenses™. This helps ensure your employees will experience their best possible vision in all situations while on the job. Then, we combine these technologies with the impact and chemical resistance of rugged polycarbonate materials. The result is workplace eyewear that is durable, accurate, comfortable, and meets all the latest ANSI Z87.1-2015 standards.
View Top Employees from Essilor Prescription Safety EyewearWebsite | http://www.essilorpse.com |
Revenue | $593.1 million |
Employees | 257 (63 on RocketReach) |
Founded | 1972 |
Address | 5205 Hwy 169 Plymouth N, Minneapolis, Minnesota 55442, US |
Phone | (800) 553-9705 |
Fax | (540) 433-2360 |
Technologies |
JavaScript,
HTML,
Google Analytics
+12 more
(view full list)
|
Industry | Drug Stores & Pharmacies, Health Care, Retail, Medical |
Competitors | Eyeglass World, Marchon Eyewear, US Vision, Walman Optical, Warby Parker |
SIC | SIC Code 38 Companies, SIC Code 385 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Essilor Prescription Safety Eyewear employee's phone or email?
The Essilor Prescription Safety Eyewear annual revenue was $593.1 million in 2023.
63 people are employed at Essilor Prescription Safety Eyewear.
Essilor Prescription Safety Eyewear is based in Minneapolis, Minnesota.
The NAICS codes for Essilor Prescription Safety Eyewear are [339, 33].
The SIC codes for Essilor Prescription Safety Eyewear are [38, 385].